MYH1 Antibody

Code CSB-PA015289ESR1HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human heart tissue using CSB-PA015289ESR1HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human skeletal muscle tissue using CSB-PA015289ESR1HU at dilution of 1:100

Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) MYH1 Polyclonal antibody
Uniprot No.
Target Names
MYH1
Alternative Names
adult 1 antibody; MYH1 antibody; MYH1_HUMAN antibody; MyHC-2x antibody; MyHC-IIx/d antibody; Myosin heavy chain 1 antibody; Myosin heavy chain 2x antibody; Myosin heavy chain antibody; Myosin heavy chain IIx/d antibody; Myosin-1 antibody; skeletal muscle antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Myosin-1 protein (1-100AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Form
Liquid
Tested Applications
ELISA, IHC
Recommended Dilution
Application Recommended Dilution
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Muscle contraction.
Gene References into Functions
  1. Transcriptional levels of MHC-I, MHC-IIa, and MHC-IIb in denervation groups were significantly down-regulated compared with controls PMID: 26059207
  2. Myosin isoforms impact single-fiber force generation and may lead to alterations in whole skeletal muscle performance. PMID: 25567808
  3. adaptive response to reduced masticatory load was lower numerical and area proportion of MyHC-1 expressing fibres and higher numerical proportion of hybrid fibres in edentulous compared with dentate subjects PMID: 22489880
  4. The human genioglossus muscle is composed of conventional myosin heavy chain isoforms and 3 primary myosin heavy chain phenotypes. PMID: 22337492
  5. the expression levels of the MHC genes are associated with age and both PGC-1alpha and PGC-1beta and indicate that the MHC genes may to some extent be used to determine fibre-type composition in human skeletal muscle. PMID: 21470888
  6. we found a higher percentage of fibers expressing fast MyHC IIx in tetraplegic cerebral palsy PMID: 17916367
  7. Modular organization of phylogenetically conserved domains controlling developmental regulation of the human skeletal gene family PMID: 11971910
  8. frequency of fibers expressing myosin heavy chain (MyHC) IIx increased in spastic paresis PMID: 17196619
  9. Patients on hemodialysis demonstrate relatively fewer type 1 and consequently more type 2x fibres, with a corresponding change in MHC isoforms (MHC I and MHC IIX) in the skeletal muscle. PMID: 17853024

Show More

Hide All

Subcellular Location
Cytoplasm, myofibril. Note=Thick filaments of the myofibrils.
Protein Families
TRAFAC class myosin-kinesin ATPase superfamily, Myosin family
Database Links

HGNC: 7567

OMIM: 160730

KEGG: hsa:4619

STRING: 9606.ENSP00000226207

UniGene: Hs.689619

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*